Is combinatorial chemistry on the right track for drug discovery?
2003

Is Combinatorial Chemistry Effective for Drug Discovery?

publication Evidence: moderate

Author Information

Author(s): Richard A. Wildonger, Tracy L. Deegan, John W. Lee

Primary Institution: AstraZeneca R&D Boston

Hypothesis

Is combinatorial chemistry on the right track for drug discovery?

Conclusion

Automation in drug synthesis can improve efficiency and reduce costs, but its effectiveness in drug discovery remains uncertain.

Supporting Evidence

  • Automation can increase drug candidate synthesis throughput.
  • High throughput synthesis has made synthetic medicinal chemists more efficient.
  • Many commercially available synthesis platforms lack the flexibility needed for effective drug discovery.

Takeaway

This study looks at how using machines to help make drugs can save time and money, but it's not clear if it actually helps find new medicines.

Methodology

The study discusses the implementation of automation in drug synthesis and its impact on efficiency and cost.

Potential Biases

Dependence on new technologies may lead to discomfort among medicinal chemists and potential misjudgment of tool adequacy.

Limitations

The effectiveness of combinatorial chemistry tools in drug discovery is not clearly established.

Digital Object Identifier (DOI)

10.1080/1463924032000121110

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication